Chemical Compound Review:
PFOA 2,2,3,3,4,4,5,5,6,6,7,7,8,8,8. ..
Synonyms:
PFOd, IPC-PFFA-8, IPC-PFFA-8 HG, AGN-PC-006VDB, CHEMBL172988, ...
Xie,
Yang,
Nelson,
DePierre,
Yang,
Xie,
Alexson,
Nelson,
DePierre,
Schedin,
Pentchev,
Dallner,
Loo,
Loo,
Hori,
Yamamoto,
Hayakawa,
Taniyasu,
Yamashita,
Kutsuna,
Kiatagawa,
Arakawa,
Petersson,
Jörntén-Karlsson,
Stålebro,
Upham,
Deocampo,
Wurl,
Trosko,
Panaretakis,
Shabalina,
Grandér,
Shoshan,
DePierre,
Kannan,
Perrotta,
Thomas,
Xie,
Yang,
Nelson,
DePierre,
Holmström,
Järnberg,
Bignert,
Yang,
Xie,
Eriksson,
Nelson,
DePierre,
Maestri,
Negri,
Ferrari,
Ghittori,
Fabris,
Danesino,
Imbriani,
Kimura,
Narazaki,
Kanazawa,
Fujiwara,
Yang,
Xie,
Depierre,
Kudo,
Suzuki-Nakajima,
Mitsumoto,
Kawashima,
Kärrman,
Mueller,
van Bavel,
Harden,
Toms,
Lindström,
- Regulation of perfluorooctanoic acid--induced peroxisomal enzyme activities and hepatocellular growth by adrenal hormones. Thottassery, J., Winberg, L., Youssef, J., Cunningham, M., Badr, M. Hepatology (1992)
- Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells. Shabalina, I.G., Panaretakis, T., Bergstrand, A., DePierre, J.W. Carcinogenesis (1999)
- Developmental Toxicity of Perfluorooctanoic Acid in the CD-1 Mouse after Cross-Foster and Restricted Gestational Exposures. Wolf, C.J., Fenton, S.E., Schmid, J.E., Calafat, A.M., Kuklenyik, Z., Bryant, X.A., Thibodeaux, J., Das, K.P., White, S.S., Lau, C.S., Abbott, B.D. Toxicol. Sci. (2007)
- Association between perfluorinated compounds and pathological conditions in southern sea otters. Kannan, K., Perrotta, E., Thomas, N.J. Environ. Sci. Technol. (2006)
- Fish oil-feeding prevents perfluorooctanoic acid-induced fatty liver in mice. Kudo, N., Kawashima, Y. Toxicol. Appl. Pharmacol. (1997)
- Perfluorooctane sulfonate influences feeding behavior and gut motility via the hypothalamus. Asakawa, A., Toyoshima, M., Fujimiya, M., Harada, K., Ataka, K., Inoue, K., Koizumi, A. Int. J. Mol. Med. (2007)
- Mixed micelles of fluorinated and hydrogenated surfactants. Nordstierna, L., Furó, I., Stilbs, P. J. Am. Chem. Soc. (2006)
- Matrix-assisted laser desorption/ionization-mass spectrometry of hydrophobic proteins in mixtures using formic Acid, perfluorooctanoic Acid, and sorbitol. Loo, R.R., Loo, J.A. Anal. Chem. (2007)
- Method for trace level analysis of c8, c9, c10, c11, and c13 perfluorocarbon carboxylic acids in water. Risha, K., Flaherty, J., Wille, R., Buck, W., Morandi, F., Isemura, T. Anal. Chem. (2005)
- The developmental toxicity of perfluoroalkyl acids and their derivatives. Lau, C., Butenhoff, J.L., Rogers, J.M. Toxicol. Appl. Pharmacol. (2004)
- Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators. Takagi, A., Sai, K., Umemura, T., Hasegawa, R., Kurokawa, Y. J. Environ. Pathol. Toxicol. Oncol. (1992)
- Synergistic induction of acyl-CoA oxidase activity, an indicator of peroxisome proliferation, by arachidonic acid and retinoic acid in Morris hepatoma 7800C1 cells. Sohlenius, A.K., Wigren, J., Bäckström, K., Andersson, K., DePierre, J.W. Biochim. Biophys. Acta (1995)
- Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice:in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase. Kudo, N., Suzuki-Nakajima, E., Mitsumoto, A., Kawashima, Y. Biol. Pharm. Bull. (2006)
- Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail. Upham, B.L., Deocampo, N.D., Wurl, B., Trosko, J.E. Int. J. Cancer (1998)
- Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Yang, Q., Xie, Y., Eriksson, A.M., Nelson, B.D., DePierre, J.W. Biochem. Pharmacol. (2001)
- 19F Magnetic resonance imaging of perfluorooctanoic acid encapsulated in liposome for biodistribution measurement. Kimura, A., Narazaki, M., Kanazawa, Y., Fujiwara, H. Magnetic resonance imaging. (2004)
- Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Yao, X., Zhong, L. Mutat. Res. (2005)
- Effects of peroxisome proliferators on the thymus and spleen of mice. Yang, Q., Xie, Y., Depierre, J.W. Clin. Exp. Immunol. (2000)
- The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice. Xie, Y., Yang, Q., Nelson, B.D., DePierre, J.W. Biochem. Pharmacol. (2003)
- Mitochondrial permeability transition as the critical target of N-acetyl perfluorooctane sulfonamide toxicity in vitro. O'Brien, T.M., Wallace, K.B. Toxicol. Sci. (2004)
- Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Panaretakis, T., Shabalina, I.G., Grandér, D., Shoshan, M.C., DePierre, J.W. Toxicol. Appl. Pharmacol. (2001)
- Determination of perfluorooctanoic acid and perfluorooctanesulfonate in human tissues by liquid chromatography/single quadrupole mass spectrometry. Maestri, L., Negri, S., Ferrari, M., Ghittori, S., Fabris, F., Danesino, P., Imbriani, M. Rapid Commun. Mass Spectrom. (2006)
- Levels of 12 perfluorinated chemicals in pooled australian serum, collected 2002-2003, in relation to age, gender, and region. Kärrman, A., Mueller, J.F., van Bavel, B., Harden, F., Toms, L.M., Lindström, G. Environ. Sci. Technol. (2006)
- Efficient decomposition of environmentally persistent perfluorocarboxylic acids by use of persulfate as a photochemical oxidant. Hori, H., Yamamoto, A., Hayakawa, E., Taniyasu, S., Yamashita, N., Kutsuna, S., Kiatagawa, H., Arakawa, R. Environ. Sci. Technol. (2005)
- Mixed adsorption of fluorinated and hydrogenated surfactants. Nordstierna, L., Furó, I., Stilbs, P. Langmuir : the ACS journal of surfaces and colloids. (2006)
- Characterization of the adipose tissue atrophy induced by peroxisome proliferators in mice. Xie, Y., Yang, Q., Nelson, B.D., DePierre, J.W. Lipids (2002)
- Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Yang, Q., Xie, Y., Alexson, S.E., Nelson, B.D., DePierre, J.W. Biochem. Pharmacol. (2002)
- Reduced cholesterol accumulation and improved deficient peroxisomal functions in a murine model of Niemann-Pick type C disease upon treatment with peroxisomal proliferators. Schedin, S., Pentchev, P., Dallner, G. Biochem. Pharmacol. (1998)
- Effects of peroxisome proliferators on rat liver phospholipids: sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid. Adinehzadeh, M., Reo, N.V. Chem. Res. Toxicol. (1998)
- Direct coupling of micellar electrokinetic chromatography to mass spectrometry using a volatile buffer system based on perfluorooctanoic acid and ammonia. Petersson, P., Jörntén-Karlsson, M., Stålebro, M. Electrophoresis (2003)
- Temporal trends of PFOS and PFOA in guillemot eggs from the Baltic Sea, 1968--2003. Holmström, K.E., Järnberg, U., Bignert, A. Environ. Sci. Technol. (2005)
- Ultraviolet-circular dichroism spectroscopy and potentiometric study of the interaction between human serum albumin and sodium perfluorooctanoate. Messina, P., Prieto, G., Dodero, V., Ruso, J.M., Schulz, P., Sarmiento, F. Biopolymers (2005)